Health Law & Life Sciences Practice Group Partner Michael Manthei will be a panelist at the Boston Bar Association's Continuing Legal Education (CLE) session titled, "The New Massachusetts Drug and Medical Device Marketing Code of Conduct and Public Reporting System." The panel will discuss the Massachusetts Department of Public Health's final issued regulation, 105 CMR 970.000, a new law which implements new restrictions, compliance programs and disclosure requirements under Massachusetts General Laws, Chapter 111N.
This event is sponsored by the Health Law Section and the Life Sciences Committee of the Intellectual Property Law Section of the Boston Bar Association. It will be held at the BBA building on Wednesday, May 6th, 2009.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.